U
ASXC

UBS’s Asensus Surgical, Inc. ASXC Stock Holding History

UBS’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-140
Closed -$9K – 10849
2014
Q2 		$9K Buy
+140
New +$8.09K ﹤0.01% 9010

Other funds holding ASXC

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

UBS's ASXC Position: Q3 2014 in Review

UBS sold out of Asensus Surgical, Inc. (ASXC) in Q3 2014, closing a stake of 140 shares — an estimated $9K sold.

UBS first reported a position in ASXC in Q2 2014 and held it in 1 quarter. The position peaked at $9K in Q2 2014. 49 funds tracked by Wall St. Rank hold ASXC as of Q3 2014.

  • UBS reported no remaining Asensus Surgical, Inc. position as of Q3 2014 after selling out during the quarter.
  • UBS sold 140 Asensus Surgical, Inc. shares in Q3 2014, an estimated $9K.
  • UBS first reported a position in Asensus Surgical, Inc. in Q2 2014 and held it in 1 quarter.
  • UBS's Asensus Surgical, Inc. position peaked at $9K in Q2 2014.
  • 49 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.